The Securities and Exchange Board of India (SEBI) has extended its temporary relaxation allowing companies to revise the size of the fresh issue component of their initial public offerings (IPOs) by up to 50% without filing fresh draft offer documents. The extension is valid for IPOs opening on or before March 31, 2027, giving companies and investment bankers additional flexibility to adjust fundraising plans without restarting the draft filing process.
The extension follows representations from the Association of Investment Bankers of India (AIBI), which highlighted the difficulties issuers face when market conditions or business requirements change after draft IPO papers have been filed. The move comes amid strong fundraising activity in India’s primary market and continuing uncertainty over valuations, investor demand and listing timelines. Companies will still need to comply with disclosure, due-diligence and other applicable regulatory requirements.
Key Takeaways
- SEBI extends the deadline: The temporary relaxation now applies to eligible IPOs opening on or before March 31, 2027.
- Up to 50% flexibility: Companies can increase or decrease the fresh issue size by up to 50% without filing fresh draft offer documents, subject to the specified conditions.
- The main purpose must remain unchanged: Issuers cannot use the relaxation to fundamentally change the principal objective of the offering.
- Disclosure obligations continue: Lead managers must update relevant offer-document sections, conduct due diligence and make an addendum public.
- Fundraising remains substantial: Companies raised ₹94,649 crore through 161 mainboard and SME IPOs during July–September 2026, according to reported market data.
- The change is procedural, not a guarantee of listing: It may make the process more flexible, but companies must still secure investor demand and meet applicable regulatory requirements.
What Has SEBI Changed in the IPO Rules?
SEBI’s extension concerns the flexibility available to companies that want to modify the size of their fresh share issue after filing draft IPO documents.
Under the temporary framework introduced in April 2026, eligible issuers could increase or decrease the fresh issue component by up to 50% without having to file an entirely new set of draft offer documents. The relaxation was initially available for issues opening by September 30, 2026. SEBI has now extended the deadline to March 31, 2027.
The change is intended to help companies respond to market movements and changing financing needs while reducing procedural delays.
The rule at a glance
| Particular | Details |
|---|---|
| Regulator | Securities and Exchange Board of India |
| Relaxation | Revision of fresh issue size by up to 50% |
| Earlier deadline | September 30, 2026 |
| Extended deadline | March 31, 2027 |
| Eligible offerings | IPOs opening on or before the extended deadline |
| Fresh draft filing | Not required for qualifying revisions under the relaxation |
| Main condition | The primary objective of the issue must remain unchanged |
| Other obligations | Updated disclosures, due diligence and a public addendum |
The relaxation does not mean that companies can change any part of an IPO without scrutiny. It is specifically designed to accommodate qualifying revisions to the fresh issue size while preserving the essential purpose of the offering and applicable investor-protection safeguards.
What Is a Fresh Issue in an IPO?
To understand the significance of the change, it is important to distinguish between the fresh issue and the offer for sale (OFS) components of an IPO.
A fresh issue involves a company issuing new shares to investors. The proceeds generally go to the company, which can use the money for purposes disclosed in its offer documents, such as expansion, debt repayment, capital expenditure or working capital.
An OFS involves existing shareholders selling their shares to public investors. In this case, the proceeds generally go to the selling shareholders rather than the company.
An IPO can include a fresh issue, an OFS or a combination of both.
Example: How the relaxation works
Suppose a company plans an IPO with a fresh issue worth ₹1,000 crore. If it later needs to revise that component by 30%, the proposed fresh issue could increase to ₹1,300 crore or decrease to ₹700 crore.
Under the temporary relaxation, a qualifying revision within the permitted 50% range can be made without filing fresh draft offer documents, provided the applicable conditions are met.
The illustration assumes the fresh issue is the relevant component being revised. The relaxation should not be interpreted as permission to alter the IPO’s primary objectives or ignore other regulatory requirements.
Why Do Companies Need Flexibility in IPO Size?
IPO plans are developed months before a company actually lists. During that period, market conditions, investor sentiment, financing requirements and business priorities can change.
A company may initially plan to raise a particular amount based on its expansion plans and valuation expectations. By the time the offering is ready to open, it may find that investors are more cautious, the cost of capital has changed or its financing requirements have increased.
Without sufficient flexibility, a material revision to the issue size could require additional documentation and procedural steps, potentially delaying the offering.
1. Market volatility can change fundraising plans
Share-market conditions affect the price investors are willing to pay for new shares. When valuations fall, a company may decide that a smaller offering is more appropriate. When demand improves, it may consider raising additional capital.
The extended relaxation gives eligible issuers greater scope to make these adjustments without automatically restarting the draft filing process.
2. Business requirements can change
Companies may revise their capital requirements because of acquisitions, expansion plans, debt repayment needs or changes in working capital requirements.
A company preparing to list may find that its original funding target no longer matches its business priorities. The ability to revise the fresh issue size can help align the proposed fundraising with the company’s current requirements, provided the main objective remains unchanged.
3. Avoiding unnecessary procedural delays
Preparing and filing offer documents involves coordination between issuers, legal advisers, auditors and merchant bankers. If a revision triggers a fresh filing process, it can add time and cost.
The relaxation is designed to reduce this friction for qualifying issue-size changes. It does not remove the need to update the disclosures that investors rely on when evaluating the offering.
Why Has SEBI Extended the Relaxation?
The extension comes as Indian companies continue to raise significant amounts of capital through the primary market.
AIBI, the industry association representing investment bankers, made representations to SEBI about practical difficulties encountered when companies and their advisers needed to revise fresh issue sizes after filing draft documents.
The extension indicates that the regulator is willing to retain a temporary procedural accommodation while primary-market activity remains substantial and issuers face changing market conditions.
However, the measure should not be interpreted as a broad relaxation of IPO eligibility requirements or a reduction in the regulator’s emphasis on transparency.
SEBI’s balancing act
The regulator must balance two objectives. Companies need an efficient process to raise capital, while investors need reliable disclosures about the size, purpose and terms of an offering.
Allowing eligible companies to revise issue sizes without filing fresh draft documents can improve efficiency. Requiring updated disclosures and due diligence helps preserve transparency when the figures change.
The effectiveness of the arrangement depends on issuers and their lead managers following these requirements carefully.
India’s IPO Market: Why the Timing Matters
The extension comes amid strong fundraising activity in India’s primary market.
According to market figures reported by The Economic Times, companies raised ₹94,649 crore through 161 mainboard and SME IPOs during July–September 2026. Mainboard offerings accounted for ₹90,482 crore, while SME IPOs raised another ₹4,167 crore.
September was particularly active, with 34 mainboard IPOs raising ₹39,381 crore and 52 SME offerings raising ₹2,123 crore.
These figures demonstrate the scale of primary-market activity during the quarter. They also help explain why a procedural change affecting IPO preparation can be important to companies and investment banks.
Reported IPO fundraising in July–September 2026
| Month | Mainboard IPOs | Mainboard funds raised | SME IPOs | SME funds raised |
|---|---|---|---|---|
| July | 12 | ₹28,648 crore | 17 | ₹891 crore |
| August | 23 | ₹22,453 crore | 23 | ₹1,153 crore |
| September | 34 | ₹39,381 crore | 52 | ₹2,123 crore |
| Quarter total | 69 | ₹90,482 crore | 92 | ₹4,167 crore |
Source: Market figures reported by The Economic Times on October 13, 2026. Figures are rounded as reported.
The activity spans companies of different sizes and sectors. It should not be assumed that every company planning an IPO will proceed with its offering or that the regulatory extension will directly increase the number of listings.
The change primarily affects the ability to revise qualifying fresh issue sizes. Actual issuance will continue to depend on company readiness, market valuations, investor demand and the applicable regulatory framework.
What Does the Extension Mean for Companies Planning IPOs?
The extension gives eligible companies additional time to benefit from the relaxation when their IPOs open on or before March 31, 2027.
Greater control over fundraising
Companies can adjust the fresh issue component to better reflect current financing requirements or market conditions, without automatically having to restart the draft filing process for a qualifying change.
Potentially lower procedural costs
Avoiding a fresh draft filing may reduce additional documentation work and related professional costs. The exact savings will depend on the circumstances of each offering.
More flexibility in launch planning
The additional six months gives eligible issuers more room to plan the timing and size of an offering. This could be particularly useful when market conditions change between the initial filing and the proposed launch.
No guarantee of a successful IPO
The extension does not guarantee regulatory clearance, investor demand or a successful listing. A company may still postpone or withdraw its offering if valuations, business conditions or market appetite deteriorate.
What Must Companies and Merchant Bankers Still Do?
The relaxation comes with conditions designed to protect investors.
The lead managers must ensure that the main objective of the IPO remains unchanged. They must update the relevant sections of the offer document to reflect the revised fresh issue size and provide the appropriate public addendum.
They must also conduct adequate due diligence, ensure compliance with applicable SEBI regulations and justify the proposed revision.
These obligations matter because changes in issue size can affect the amount of capital a company receives and the information investors use to assess the transaction.
For example, a larger fresh issue may alter the company’s post-IPO shareholding structure and the extent of dilution experienced by existing shareholders. A smaller issue could mean the company raises less capital than initially planned, potentially affecting how it finances its disclosed objectives.
Investors should therefore review updated offer documents rather than relying solely on the original IPO announcement.
What Could the Change Mean for Investors?
For investors, the main benefit is a potentially more adaptable IPO process. Companies may be able to adjust the size of their offerings to reflect market conditions without facing the same procedural burden associated with starting a fresh draft filing process.
However, greater flexibility also makes it important to monitor updated disclosures.
Investors evaluating an IPO should consider:
- Whether the revised issue size changes the company’s funding plan.
- Whether the proceeds remain aligned with the disclosed objectives.
- How the revised offering affects dilution and post-listing shareholding.
- Whether the company’s valuation remains reasonable.
- Whether market conditions support the proposed issue price and size.
A change in the issue size is not, by itself, a positive or negative signal. Its implications depend on why the company is making the revision and how that change affects its financial position and future plans.
The Bigger Picture
SEBI’s extension reflects an effort to make India’s IPO process more adaptable without abandoning disclosure and due-diligence requirements. For companies, the relaxation can reduce procedural friction when the proposed fresh issue size needs to change. For investment bankers, it provides additional flexibility when advising issuers on fundraising plans in a changing market.
The broader significance lies in the balance between market efficiency and investor protection. A flexible process can help companies respond to changing financing needs, but the quality of disclosures remains essential. The success of the measure will depend on how responsibly issuers and their advisers use the additional flexibility and how effectively investors are informed about material revisions.
Looking Ahead
The extended window runs until March 31, 2027, for eligible IPOs opening by that date. Companies preparing to list may use the additional time to reassess their fundraising requirements and proposed issue sizes as market conditions evolve. The relaxation should make qualifying revisions easier to manage, but it does not guarantee that an offering will proceed or attract sufficient investor demand.
Investors should watch for revised offer documents, public addenda and announcements from companies adjusting their IPO plans. The key questions will remain whether the revised size matches the company’s financing needs, whether the primary objective is unchanged and whether the valuation and disclosures support an informed investment decision.
Frequently Asked Questions
What has SEBI extended until March 2027?
SEBI has extended a temporary relaxation allowing eligible IPO issuers to increase or decrease their fresh issue size by up to 50% without filing fresh draft offer documents, subject to specified conditions.
What is the new deadline?
The relaxation applies to IPOs opening on or before March 31, 2027. It was previously available for offerings opening by September 30, 2026.
Can a company change the purpose of its IPO under this relaxation?
No. The primary objective of the issue must remain unchanged for the issuer to use the relaxation. Applicable disclosure and regulatory requirements continue to apply.
Does the relaxation eliminate SEBI’s review and disclosure requirements?
No. Lead managers must conduct due diligence, update relevant offer-document sections, comply with applicable regulations, justify the revision and make an addendum public.
How does this affect IPO investors?
It can allow companies to adjust fundraising plans more efficiently. Investors should still review updated offer documents and assess how a change in issue size affects the company’s financing plans, dilution and valuation.
Will the extension lead to more IPOs in India?
It may reduce procedural hurdles for some companies, but it does not guarantee more listings. IPO activity will continue to depend on market conditions, valuations, investor demand and company readiness.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
